Assessment of vulvar discomfort with sexual activity among women in the United States

Published:December 14, 2016DOI:


      Multidimensional self-report measures of sexual function for women do not include the assessment of vulvar discomfort, limiting our understanding of its prevalence. In an effort to improve the measurement of patient-reported health, the National Institutes of Health funded the creation of the Patient Reported Outcomes Measurement Information System (PROMIS). This included the development of the PROMIS Sexual Function and Satisfaction measure, and version 2.0 of the Sexual Function and Satisfaction measure included 2 scales to measure vulvar discomfort with sexual activity.


      The objectives of the study were to describe the development of 2 self-reported measures of vulvar discomfort with sexual activity, describe the relationships between these scales and scales for lubrication and vaginal discomfort, and report the prevalence of vulvar discomfort with sexual activity in a large, nationally representative sample of US women.

      Study Design

      We followed PROMIS measure development standards, including qualitative development work with patients and clinicians and psychometric evaluation of candidate items based on item response theory, in a probability sample of 1686 English-speaking US adult women. We tested 16 candidate items on vulvar discomfort. We present descriptive statistics for these items, correlation coefficients among the vulvar and vaginal scales, and mean PROMIS scores with 95% confidence intervals separately by menopausal status for the 1046 women who reported sexual activity in the past 30 days.


      Based on the psychometric evaluation of the candidate items, we created 2 separate 4 item scales, one to measure labial discomfort and pain and one to measure clitoral discomfort and pain. Additional items not included in the scales assess pain quality, numbness, and bleeding. The correlations between the lubrication, vaginal discomfort, and the 2 vulvar discomfort measures ranged from 0.46 to 0.77, suggesting that these measures represent related yet distinct concepts. In our nationally representative sample, 1 in 5 US women endorsed some degree of vulvar discomfort with sexual activity in the past 30 days. Menopausal status was associated with lower lubrication and higher vaginal discomfort but not with vulvar discomfort.


      The PROMIS Vulvar Discomfort with Sexual Activity–Labial and Vulvar Discomfort with Sexual Activity–Clitoral scales are publicly available for use in research and clinical settings. There is limited overlap between vulvar discomfort and lubrication or vaginal discomfort. The importance of measuring vulvar discomfort as part of a comprehensive assessment of sexual function is underscored by its prevalence.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bornstein J.
        • Goldstein A.T.
        • Stockdale C.K.
        • et al.
        2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia.
        Obstet Gynecol. 2016; 127: 745-751
        • Ben-Aroya Z.
        • Edwards L.
        Semin Cutan Med Surg. 2015; 34: 192-198
        • Leusink P.
        • Kaptheijns A.
        • Laan E.
        • van Boven K.
        • Lagro-Janssen A.
        Comorbidities among women with vulvovaginal complaints in family practice.
        J Sex Med. 2016; 13: 220-225
        • Burger M.P.
        • Obdeijn M.C.
        Complications after surgery for the relief of dyspareunia in women with lichen sclerosus: a case series.
        Acta Obstet Gynecol Scand. 2016; 95: 467-472
        • Thorstensen K.A.
        • Birenbaum D.L.
        Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus.
        J Midwifery Womens Health. 2012; 57: 260-275
        • Simonetta C.
        • Burns E.K.
        • Guo M.A.
        Vulvar dermatoses: a review and update.
        Mo Med. 2015; 112: 301-307
        • Goetsch M.F.
        • Lim J.Y.
        • Caughey A.B.
        Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial.
        Obstet Gynecol. 2014; 123: 1231-1236
        • Flynn K.E.
        • Lin L.
        • Cyranowski J.M.
        • et al.
        Development of the NIH PROMIS® Sexual Function and Satisfaction Measures in patients with cancer.
        J Sex Med. 2013; 10: 43-52
        • Weinfurt K.P.
        • Lin L.
        • Bruner D.W.
        • et al.
        Development and initial validation of the PROMIS((R)) Sexual Function and Satisfaction Measures Version 2.0.
        J Sex Med. 2015; 12: 1961-1974
        • Flynn K.E.
        • Jeffery D.D.
        • Keefe F.J.
        • et al.
        Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)).
        Psychooncology. 2011; 20: 378-386
        • Alexander A.M.
        • Flynn K.E.
        • Hahn E.A.
        • et al.
        Improving patients' understanding of terms and phrases commonly used in self-reported measures of sexual function.
        J Sex Med. 2014; 11: 1991-1998
      1. Knowledge Networks. KnowledgePanel design summary. 2014.

        • Reeve B.B.
        • Hays R.D.
        • Bjorner J.B.
        • et al.
        Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).
        Med Care. 2007; 45: S22-S31
        • Laumann E.O.
        • Paik A.
        • Rosen R.C.
        Sexual dysfunction in the United States: prevalence and predictors.
        JAMA. 1999; 281: 537-544
        • Lindau S.T.
        • Schumm L.P.
        • Laumann E.O.
        • Levinson W.
        • O'Muircheartaigh C.A.
        • Waite L.J.
        A study of sexuality and health among older adults in the United States.
        N Engl J Med. 2007; 357: 762-774
        • Reed B.D.
        • Harlow S.D.
        • Sen A.
        • et al.
        Prevalence and demographic characteristics of vulvodynia in a population-based sample.
        Am J Obstet Gynecol. 2012; 206: 170.e1-170.e9
        • Reed B.D.
        • Haefner H.K.
        • Harlow S.D.
        • Gorenflo D.W.
        • Sen A.
        Reliability and validity of self-reported symptoms for predicting vulvodynia.
        Obstet Gynecol. 2006; 108: 906-913
        • Nappi R.E.
        • Palacios S.
        • Panay N.
        • Particco M.
        • Krychman M.L.
        Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
        Climacteric. 2016; 19: 188-197
        • Parish S.J.
        • Nappi R.E.
        • Krychman M.L.
        • et al.
        Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy.
        Int J Womens Health. 2013; 5: 437-447
        • Erekson E.A.
        • Yip S.O.
        • Wedderburn T.S.
        • et al.
        The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women.
        Menopause. 2013; 20: 973-979
        • Parada M.
        • D'Amours T.
        • Amsel R.
        • Pink L.
        • Gordon A.
        • Binik Y.M.
        Clitorodynia: a descriptive study of clitoral pain.
        J Sex Med. 2015; 12: 1772-1780